NRs also displayed inhibitory and anti-cancer effects in PCa cells in order far more potent than FDA approved PCa drugs, established MNK inhibitors and clinically relevant retinoids, with nominal effects on immortalized untransformed prostate cells. The gene discussed is ATP7A; the disease is posterior cortical atrophy.